[Solution] A pharmaceutical composition for the prevention or treatment of diabetes, type 2 diabetes, preservation of beta-cell function, obesity, non-alcoholic steatohepatitis, and degenerative neurological diseases, comprising semaglutide or a salt thereof, a bioavailability improving agent, and a biodegradable polymer-based sustained-release microglobules, wherein the semaglutide or a salt thereof is present in an amount of 8% by weight or more of semaglutide relative to the total weight of the microglobules, and the bioavailability improving agent is present in an amount of 2.5% to 250% by weight relative to the weight of semaglutide, and a method for producing the same
Testing Methodology We tested the Zeee battery using three main methods: a 105A load test, a C rating test, and an internal resistance test
Importance of apoptosis in the histopathology of drug related lesions in the large intestine
Mold Related to Glutathione As we age, our natural production of glutathione decreases which results in free radical damage and oxidative stress